Literature DB >> 18199643

Expression of transgenes from newcastle disease virus with a segmented genome.

Qinshan Gao1, Man-Seong Park, Peter Palese.   

Abstract

Paramyxoviruses belong to the Paramyxoviridae family of the order Mononegavirales. They have a nonsegmented negative-stranded RNA genome and can cause a number of diseases in humans and animals. We generated a recombinant Newcastle disease virus (NDV) possessing a two-segmented genome. Each genomic segment is flanked by authentic NDV 3' and 5' noncoding termini allowing for efficient replication and transcription. A reporter gene encoding green fluorescent protein (GFP) was inserted into one segment, and a red fluorescent protein dsRed gene was inserted into the other segment in order to easily detect the replication and transcription of segments in infected cells. The rescued viruses grew well and were stable in embryonated chicken eggs over multiple passages. We were able to detect the expression of both reporter genes in the same cell infected with the virus possessing a segmented genome, and viral particles can contain either one or two types of RNA segments. We also rescued a two-segmented virus expressing GFP and the severe acute respiratory syndrome-associated coronavirus spike S protein, which is about 200 kDa. The chimeric virus extends the coding capacity of NDV by 30%, suggesting that the two-segmented NDV can be used for development of vaccines or gene therapy vectors carrying long and multiple transgenes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18199643      PMCID: PMC2258964          DOI: 10.1128/JVI.02341-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  36 in total

1.  Long nucleotide insertions between the HN and L protein coding regions of human parainfluenza virus type 3 yield viruses with temperature-sensitive and attenuation phenotypes.

Authors:  M H Skiadopoulos; S R Surman; A P Durbin; P L Collins; B R Murphy
Journal:  Virology       Date:  2000-06-20       Impact factor: 3.616

2.  Polyploid measles virus with hexameric genome length.

Authors:  Monika Rager; Sompong Vongpunsawad; William Paul Duprex; Roberto Cattaneo
Journal:  EMBO J       Date:  2002-05-15       Impact factor: 11.598

3.  Recombinant Newcastle disease virus as a vaccine vector.

Authors:  T Nakaya; J Cros; M S Park; Y Nakaya; H Zheng; A Sagrera; E Villar; A García-Sastre; P Palese
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

4.  Generation of recombinant lentogenic Newcastle disease virus from cDNA.

Authors:  Angela Römer-Oberdörfer; Egbert Mundt; Teshome Mebatsion; Ursula J Buchholz; Thomas C Mettenleiter
Journal:  J Gen Virol       Date:  1999-11       Impact factor: 3.891

5.  Phase I trial of intravenous administration of PV701, an oncolytic virus, in patients with advanced solid cancers.

Authors:  Andrew L Pecora; Naiyer Rizvi; Gary I Cohen; Neal J Meropol; Daniel Sterman; John L Marshall; Stuart Goldberg; Peter Gross; James D O'Neil; William S Groene; M Scot Roberts; Harvey Rabin; Michael K Bamat; Robert M Lorence
Journal:  J Clin Oncol       Date:  2002-05-01       Impact factor: 44.544

6.  Immunization of primates with a Newcastle disease virus-vectored vaccine via the respiratory tract induces a high titer of serum neutralizing antibodies against highly pathogenic avian influenza virus.

Authors:  Joshua M DiNapoli; Lijuan Yang; Amorsolo Suguitan; Subbiah Elankumaran; David W Dorward; Brian R Murphy; Siba K Samal; Peter L Collins; Alexander Bukreyev
Journal:  J Virol       Date:  2007-08-22       Impact factor: 5.103

7.  MTH-68/H oncolytic viral treatment in human high-grade gliomas.

Authors:  L K Csatary; G Gosztonyi; J Szeberenyi; Z Fabian; V Liszka; B Bodey; C M Csatary
Journal:  J Neurooncol       Date:  2004 Mar-Apr       Impact factor: 4.130

Review 8.  Overview of phase I studies of intravenous administration of PV701, an oncolytic virus.

Authors:  Robert M Lorence; Andrew L Pecora; Pierre P Major; Sebastien J Hotte; Scott A Laurie; M Scot Roberts; William S Groene; Michael K Bamat
Journal:  Curr Opin Mol Ther       Date:  2003-12

9.  Efficient recovery of infectious vesicular stomatitis virus entirely from cDNA clones.

Authors:  S P Whelan; L A Ball; J N Barr; G T Wertz
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-29       Impact factor: 11.205

10.  A highly recombinogenic system for the recovery of infectious Sendai paramyxovirus from cDNA: generation of a novel copy-back nondefective interfering virus.

Authors:  D Garcin; T Pelet; P Calain; L Roux; J Curran; D Kolakofsky
Journal:  EMBO J       Date:  1995-12-15       Impact factor: 11.598

View more
  12 in total

1.  A majority of infectious Newcastle disease virus particles contain a single genome, while a minority contain multiple genomes.

Authors:  Peter H Goff; Qinshan Gao; Peter Palese
Journal:  J Virol       Date:  2012-07-11       Impact factor: 5.103

2.  Detection of free peritoneal cancer cells in gastric cancer using cancer-specific Newcastle disease virus.

Authors:  Joyce Wong; Allison Schulman; Kaitlyn Kelly; Dmitriy Zamarin; Peter Palese; Yuman Fong
Journal:  J Gastrointest Surg       Date:  2009-11-10       Impact factor: 3.452

3.  Engineered intermonomeric disulfide bonds in the globular domain of Newcastle disease virus hemagglutinin-neuraminidase protein: implications for the mechanism of fusion promotion.

Authors:  Paul J Mahon; Anne M Mirza; Thomas A Musich; Ronald M Iorio
Journal:  J Virol       Date:  2008-08-27       Impact factor: 5.103

4.  Glycoprotein interactions in paramyxovirus fusion.

Authors:  Ronald M Iorio; Vanessa R Melanson; Paul J Mahon
Journal:  Future Virol       Date:  2009-07-01       Impact factor: 1.831

5.  Optimization of human immunodeficiency virus gag expression by newcastle disease virus vectors for the induction of potent immune responses.

Authors:  Elena Carnero; Wenjing Li; Antonio V Borderia; Bruno Moltedo; Thomas Moran; Adolfo García-Sastre
Journal:  J Virol       Date:  2008-11-12       Impact factor: 5.103

6.  The influenza virus protein PB1-F2 inhibits the induction of type I interferon at the level of the MAVS adaptor protein.

Authors:  Zsuzsanna T Varga; Irene Ramos; Rong Hai; Mirco Schmolke; Adolfo García-Sastre; Ana Fernandez-Sesma; Peter Palese
Journal:  PLoS Pathog       Date:  2011-06-09       Impact factor: 6.823

7.  Inhibition of Pseudomonas aeruginosa with a recombinant RNA-based viral vector expressing human β-defensin 4.

Authors:  Sehee Park; Jin Il Kim; Ilseob Lee; Joon-Yong Bae; Min-Woong Hwang; Donghwan Kim; Seok-Il Jang; Hyejin Kim; Mee Sook Park; Hyung-Joo Kwon; Jin-Won Song; Yong Suk Cho; Wook Chun; Man-Seong Park
Journal:  BMC Microbiol       Date:  2014-09-27       Impact factor: 3.605

8.  Reverse Genetics of Newcastle Disease Virus.

Authors:  Stivalis Cardenas-Garcia; Claudio L Afonso
Journal:  Methods Mol Biol       Date:  2017

Review 9.  Peste des petits ruminants.

Authors:  S Parida; M Muniraju; M Mahapatra; D Muthuchelvan; H Buczkowski; A C Banyard
Journal:  Vet Microbiol       Date:  2015-09-05       Impact factor: 3.293

Review 10.  Recombinant vectors as influenza vaccines.

Authors:  Sarah A Kopecky-Bromberg; Peter Palese
Journal:  Curr Top Microbiol Immunol       Date:  2009       Impact factor: 4.291

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.